Wall Street analysts have grown increasingly bullish on Birkenstock Holding plc (BIRK.US), the pioneer of anatomical sandals, driven by the company's strong recent performance data and the better-than-expected impact of Trump's tariff policies on its fundamentals. Some analysts are even declaring the company's investment prospects superior to athletic brands Nike and Adidas, positioning it as one of the world's best footwear stocks.

UBS stock market analyst Jay Sole recently raised the company's target price from $76 to $77 while maintaining a "Buy" rating, based on strong expected growth in Birkenstock demand and emphasizing that the impact from Trump administration tariff pressures will be very short-term and more optimistic than anticipated.

The bullish outlook from UBS analysts comes ahead of Birkenstock Holding plc's exceptionally strong fiscal third quarter 2025 (FQ3) earnings report. As of Tuesday's market close, Birkenstock shares traded at $50.13, suggesting potential upside of up to 50% over the next 12 months according to UBS analysts, potentially launching a new bull market run and completely reversing the stock's decline of over 10% year-to-date.

Latest financial data shows Birkenstock Holding plc achieved 16% revenue growth on a constant currency basis in FQ3, while reported revenue growth was approximately 12%, with both figures exceeding Wall Street analyst expectations. This double-digit growth appeared across all business segments and channels, with the Americas, EMEA (Europe, Middle East, and Africa), and APAC (Asia-Pacific) markets achieving year-over-year growth of 16%, 13%, and 24% respectively on a constant currency basis.

The company's B2B sales channel was a key driver, with B2B revenue growing 18% on a constant currency basis, outpacing the D2C channel. Total revenue for the quarter reached $739.62 million, surpassing Wall Street analyst expectations. The company successfully implemented price increases on core products during the third quarter without significant negative market reaction.

Birkenstock Holding plc is also expanding its direct-to-consumer retail footprint, having added 13 new stores globally, with a core growth target of reaching approximately 100 stores worldwide by the end of fiscal 2025.

Birkenstock Holding plc is the originator of the globally popular Birkenstock sandal category, primarily engaged in the production, manufacturing, and sales of Birkenstock footwear products. Its product range also includes skincare products and distinctive accessories. "Birkenstock shoes" are typically defined as trendy sandals "with anatomical arched cork-latex footbeds." Birkenstock Holding plc is both the originator of this category and the inventor of the core footbed technology.

The core of Birkenstock shoes lies in the cork-latex footbed, which provides shock absorption, arch support, pressure distribution, and good foot microclimate functions. This wearing experience and "healthy walking" concept provides significant comfort advantages in long-standing and commuting scenarios. The so-called "Birkenstock fever" refers to the global popularity of this "healthy walking" concept sandal product line in recent years, driven both by genuine comfort and health functions, as well as sustainable narratives, cultural diffusion, and high-end fashion repackaging.